NCT04293861 - Evaluation of the Evolution of Biological and Imaging Markers of Bone and Cartilage Degradation in Patients With Knee Osteoarthritis Receiving Intra-articular Injections of a Hyaluronan Derivative HYMOVIS® | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

June 6, 2017

Study Completion Date

June 6, 2017

Conditions

Knee Osteoarthritis

Interventions

DEVICE

HYMOVIS

HYMOVIS is a clear hydrogel obtained by hydration of the HA-based derivative named HYADD4p5. The conjugate compound is constituted by a partial hexadecylamide of hyaluronic acid, which is produced by a fermentation process.

Trial Locations (8)

1020

Service de Rhumatologie, CHU Brugmann, Brussels

4000

CHR Citadelle de Liège, Liège

Service de Rhumatologie CHU Liège, Liège

5530

Service de Rhumatologie CHU Dinant-Godinne (Site Godinne), Yvoir

10499

Centre Hospitalier Nord Franche-Comté, Trévenans

69003

Hopital Edouard Herriot (Lyon), Lyon

75010

Service de rhumatologie,RDC Hôpital Lariboisière, Paris

60327 57126

Service de Rhumatologie CHR Metz Thionville Hôpital Bel Air, Thionville